Vascular endothelial growth factor as a marker of tumor endothelium

RA Brekken, X Huang, SW King, PE Thorpe - Cancer research, 1998 - AACR
Vascular endothelial growth factor (VEGF) is an angiogenic growth factor that is a primary
stimulant of the vascularization of solid tumors. VEGF production is induced by oncogenic …

VEGF–VEGF receptor complexes as markers of tumor vascular endothelium

RA Brekken, PE Thorpe - Journal of Controlled Release, 2001 - Elsevier
Vascular endothelial growth factor (VEGF) is a primary stimulant of the vascularization of
solid tumors and has therefore been the focus of intense research aimed at blocking its …

Selective inhibition of vascular endothelial growth factor (VEGF) receptor 2 (KDR/Flk-1) activity by a monoclonal anti-VEGF antibody blocks tumor growth in mice

RA Brekken, JP Overholser, VA Stastny… - Cancer research, 2000 - AACR
Vascular endothelial growth factor (VEGF) is a multifunctional angiogenic growth factor that
is a primary stimulant of the development and maintenance of a vascular network in …

Expression and functional significance of vascular endothelial growth factor receptors in human tumor cells.

C Herold-Mende, HH Steiner, T Andl… - … ; a Journal of …, 1999 - europepmc.org
Vascular endothelial growth factor (VEGF) is one of the key factors in tumor
neoangiogenesis, acting through its receptors KDR (VEGFR-2) and fit-1 (VEGFR-1) …

Evaluation of novel antimouse VEGFR2 antibodies as potential antiangiogenic or vascular targeting agents for tumor therapy

S Ran, X Huang, A Downes, PE Thorpe - Neoplasia, 2003 - Elsevier
We generated a panel of eight rat IgG 2a monoclonal antibodies with high affinity for mouse
VEGFR2 (KDR/Flk-1), the main receptor that mediates the angiogenic effect of VEGF-A. The …

Vascular endothelial growth factor and vascular targeting of solid tumors.

RA Brekken, PE Thorpe - Anticancer research, 2001 - europepmc.org
Vascular targeting agents, which selectively destroy tumor blood vessels, are attractive
agents for the treatment of solid tumors. They differ from anti-angiogenic agents in that they …

VEGF as a key mediator of angiogenesis in cancer

P Carmeliet - Oncology, 2005 - karger.com
Vascular endothelial growth factor (VEGF) is a homodimeric glycoprotein with a molecular
weight of approximately 45 kDa. It is the key mediator of angiogenesis (the formation of new …

VEGF-mediated tumour angiogenesis: a new target for cancer therapy

G Martiny-Baron, D Marmé - Current opinion in Biotechnology, 1995 - Elsevier
Considerable evidence is gathering for the involvement of vascular endothelial growth factor
(VEGF) in the vascularization and growth of primary tumours as well as in the formation of …

Expression of vascular endothelial growth factor (VEGF) and VEGF receptors in human neuroblastomas

I Langer, P Vertongen, J Perret… - Medical and …, 2000 - Wiley Online Library
Background Vascular endothelial growth factor (VEGF) is a specific endothelial cell mitogen
that stimulates angiogenesis and plays a crucial role in tumor growth. The aim of the present …

Vascular endothelial growth factor receptors VEGFR-2 and VEGFR-3 are localized primarily to the vasculature in human primary solid cancers

NR Smith, D Baker, NH James, K Ratcliffe… - Clinical Cancer …, 2010 - AACR
Purpose: Vascular endothelial growth factor (VEGF) signaling is key to tumor angiogenesis
and is an important target in the development of anticancer drugs. However, VEGF receptor …